Company intelligence / Profile preview

Umbulizer

Cambridge, Massachusetts, United Statesumbulizer.com ↗

Ownership: Private
Development stage: Commercial

Overview

Umbulizer has developed the UMV-001, a portable, low-cost ventilator that has undergone extensive benchtop and human factors validation. A year-long randomized clinical trial on ICU patients was completed in late 2019, demonstrating safety and similar efficacy to standard-of-care ventilators. The UMV-001 received FDA Emergency Use Authorization for use in adults with acute respiratory failure during the COVID-19 pandemic

Therapeutic areas: Pulmonology
Modalities: Device (specifically, ventilator/respiratory support device)
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Umbulizer.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Umbulizer.

Explore the full profile